This panel will explore how evolving drug pricing policy and site-neutral payment proposals could reshape the financial and operational landscape for cancer programs. Speakers will discuss the potential implications for reimbursement, infusion services and where oncology care is delivered across hospital and community settings. The conversation will examine how leaders will monitor regulatory developments, assess risk to their programs and plan for a range of policy outcomes. Attendees will hear perspectives on preparing oncology service lines to remain financially sustainable while maintaining patient access to care.